# Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

> **NCT00238277** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 15 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** chemotherapy
- **PROCEDURE:** radiation therapy

## Key facts

- **NCT ID:** NCT00238277
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02-15
- **Primary completion:** 2007-12-11
- **Final completion:** 2007-12-11
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Terminated - due to low accrual
- **Last updated:** 2018-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238277, "Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00238277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*